LLY vs TECH · P/E 39, rev $65.18B vs P/E 65, rev $1.22B
Eli Lilly and Company (LLY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LLY and TECH stock pages for the full models.
Not investment advice.